« Trump likely to sign executive order banning Chinese telecom equipment
Jeff Bezos applauded for going public about ‘extortion’ attempt »
Feb 07 2019

Diabetes moves down the list of priorities for big pharma

Posted by: moneycentralmsn in MSN Money

While Sanofi and other Big Pharma companies rush toward cutting-edge therapies that unleash the immune system to fight cancer or potentially cure DNA flaws, diabetes is moving down the list of priorities.

More…

This entry was posted on Thursday, February 7th, 2019 at 11:54 pm and is filed under MSN Money. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

  • Search